MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 275 filers reported holding MYRIAD GENETICS INC in Q4 2013. The put-call ratio across all filers is 4.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $7,332,000,000 | -56.3% | 207,132 | -74.1% | 0.16% | -49.0% |
Q4 2013 | $16,784,000,000 | -34.4% | 800,000 | -26.6% | 0.31% | -42.1% |
Q3 2013 | $25,596,000,000 | +27.0% | 1,089,206 | +45.2% | 0.53% | +40.7% |
Q2 2013 | $20,152,000,000 | – | 750,000 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tieton Capital Management, LLC | 160,434 | $4,457,000 | 3.90% |
KESTREL INVESTMENT MANAGEMENT CORP | 231,875 | $6,441,000 | 3.04% |
SG Capital Management LLC | 501,818 | $13,941,000 | 2.21% |
DISCIPLINED GROWTH INVESTORS INC /MN | 2,707,364 | $75,211,000 | 1.40% |
Global Alpha Capital Management Ltd. | 269,000 | $7,473,000 | 1.30% |
S&T BANK/PA | 166,772 | $4,633,000 | 1.02% |
MARATHON CAPITAL MANAGEMENT | 79,460 | $2,207,000 | 0.90% |
Taylor Frigon Capital Management LLC | 45,903 | $1,275,000 | 0.88% |
PURA VIDA INVESTMENTS, LLC | 200,000 | $5,556,000 | 0.84% |
Millrace Asset Group, Inc. | 29,222 | $812,000 | 0.84% |